Evidence map›Paper›PMID 36668907›Full record

ArticleApplied neuropsychology. Adult

Differences in rates of impairment in adults who use methamphetamine using two sets of demographically corrected norms.

Kate Shirley, Maya O'Neil, Stephen Boyd, Jennifer M Loftis

Open access · greenAbstract read
In one paragraph

Article in Applied neuropsychology. Adult. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kate ShirleyResearch & Development Service, VA Portland Health Care System, Portland, OR, USA.ORCID 0000-0001-6226-531X
Maya O'NeilResearch & Development Service, VA Portland Health Care System, Portland, OR, USA.
Stephen BoydDepartment of Anesthesiology and Perioperative Medicine, School of Medicine, Oregon Health & Science University, Portland, OR, USA.
Jennifer M LoftisResearch & Development Service, VA Portland Health Care System, Portland, OR, USA.
Oregon Health & Science University · US

Funding

Validation of CD74 as a treatment target for methamphetamine use disorderU18DA052351 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HUCKANS, MARILYN, LOFTIS, JENNIFER M · 2020 to 2020
$199k
HCV and co-morbid alcohol use disorders: a translational investigation of antiviral therapy outcomes on CNS functionI01BX002061 · VA · PORTLAND VA MEDICAL CENTER · PI LOFTIS, JENNIFER M · 2014 to 2023
–
BLRD VA I01 BX002061NIDA NIH HHS U18 DA052351
6 · The paper itself

Abstract

Neuropsychologists can expect to meet with increasing rates of patients who use methamphetamine (MA), as MA use is on the rise, often comorbid with other substance use disorders, and frequently accompanied by changes in cognitive functioning. To detect impairment, neuropsychologists must apply the appropriate normative data according to important demographic factors such as age, sex, and education. This study involved 241 adults with and without MA dependence who were administered the Neuropsychological Assessment Battery. Given the high rates of polysubstance use among adults who use MA, we included adults with mono-dependence and poly-dependence on MA and at least one other substance. We compared the rates of adults with and without previous MA dependence classified as impaired on neurocognitive testing when using norms corrected for age, education, and sex versus norms corrected only for age. Norms corrected for age, education, and sex resulted in less frequent identification of impairment compared to norms corrected only for age, but both sets of norms appeared sufficient and similar enough to warrant their use with this population. It may be appropriate to explore the possible implications of discrepancies between education-corrected and non-education corrected sets of scores when assessing impairment in individuals who use MA.

Indexed as

Amphetamine-Related DisordersCentral Nervous System StimulantsCognitive DysfunctionMethamphetamineNeuropsychological TestsAdultAge FactorsFemaleHumansMaleMiddle AgedYoung AdultCentral Nervous System StimulantsMethamphetamineCognitionneuropsychologynormative datastimulantsubstance use disorder

Identifiers

PMID36668907
PMCPMC10356906
OpenAlexW4317679613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.